OPC Pharmaceutical JSC (HOSE:OPC)
Vietnam · Delayed Price · Currency is VND 20,800
0.00 (0.00%)
At close: Aug 27, 2026
OPC Pharmaceutical JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,558,742 | 1,537,221 | 1,601,272 | 1,537,221 | 1,761,400 | 1,520,220 | |
Market Cap Growth | 8.16% | -4.00% | 4.17% | -12.73% | 15.87% | -3.87% |
Enterprise Value | 1,298,252 | 1,283,138 | 1,427,427 | 1,373,942 | 1,619,033 | 1,592,204 |
Last Close Price | 20800.00 | 19805.48 | 20630.71 | 18635.87 | 20032.01 | 17289.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.41 | 15.61 | 16.96 | 14.84 | 13.75 | 13.46 |
PS Ratio | 1.35 | 1.37 | 1.65 | 1.53 | 1.50 | 1.35 |
PB Ratio | 1.61 | 1.58 | 1.83 | 1.74 | 2.02 | 2.05 |
P/TBV Ratio | 1.88 | 1.84 | 2.17 | 2.06 | 2.40 | 2.51 |
P/FCF Ratio | 57.23 | 36.89 | 131.82 | 6.32 | 61.40 | 8.36 |
P/OCF Ratio | 32.88 | 25.65 | 67.49 | 6.02 | 48.81 | 7.97 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.13 | 1.14 | 1.47 | 1.37 | 1.38 | 1.42 |
EV/EBITDA Ratio | 8.21 | 8.34 | 9.11 | 8.13 | 8.04 | 8.41 |
EV/EBIT Ratio | 9.49 | 9.70 | 10.62 | 9.40 | 9.06 | 9.55 |
EV/FCF Ratio | 47.66 | 30.79 | 117.51 | 5.65 | 56.44 | 8.76 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | - | - | - | 0.10 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.38 |
Debt / FCF Ratio | - | - | - | - | - | 0.39 |
Net Debt / Equity Ratio | -0.34 | -0.33 | -0.28 | -0.36 | -0.36 | -0.20 |
Net Debt / EBITDA Ratio | -2.08 | -2.08 | -1.58 | -1.90 | -1.56 | -0.78 |
Net Debt / FCF Ratio | -11.93 | -7.66 | -20.36 | -1.32 | -10.99 | -0.81 |
Asset Turnover | 0.89 | 0.87 | 0.78 | 0.80 | 0.94 | 0.94 |
Inventory Turnover | 1.47 | 1.49 | 1.41 | 1.37 | 1.37 | 1.21 |
Quick Ratio | 1.52 | 1.59 | 1.47 | 1.46 | 1.30 | 0.71 |
Current Ratio | 2.75 | 2.72 | 2.66 | 2.50 | 2.47 | 1.81 |
Return on Equity (ROE) | 12.65% | 12.57% | 12.43% | 13.93% | 17.63% | 16.97% |
Return on Assets (ROA) | 6.48% | 6.38% | 6.77% | 7.29% | 8.99% | 8.72% |
Return on Invested Capital (ROIC) | 15.19% | 16.18% | 18.00% | 20.56% | 24.52% | 19.97% |
Return on Capital Employed (ROCE) | 13.80% | 13.40% | 15.20% | 16.40% | 20.40% | 22.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.49% | 7.54% | 6.69% | 7.95% | 8.07% | 8.31% |
FCF Yield | 1.75% | 2.71% | 0.76% | 15.83% | 1.63% | 11.96% |
Dividend Yield | 3.29% | 3.45% | - | 6.88% | 6.40% | - |
Payout Ratio | 59.25% | - | 89.62% | 78.40% | 18.70% | 42.26% |
Buyback Yield / Dilution | - | - | - | - | - | 0.00% |
Total Shareholder Return | 3.26% | 3.45% | - | 6.88% | 6.40% | 0.00% |